The impact of coronary artery disease severity on long-term outcomes in unprotected left main coronary artery

Serkan Kahraman1, Hicaz Zencirkiran Agus1, Gökhan Demirci1

  • 1Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, İstanbul, Turkey.

Insights

Coronary artery disease severity predicts outcomes after left main coronary artery percutaneous coronary intervention (PCI). Higher SYNTAX scores and residual SYNTAX scores indicate increased risk of adverse cardiovascular events and mortality.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine
  • Clinical Research

Background:

  • Optimal treatment for left main coronary artery (LMCA) disease remains debated.
  • Percutaneous coronary intervention (PCI) is an alternative to surgery for LMCA disease.
  • Understanding long-term prognostic factors is crucial for patient management.

Purpose of the Study:

  • To identify long-term prognostic determinants in patients undergoing LMCA PCI.
  • To evaluate the impact of coronary artery disease (CAD) severity on outcomes after LMCA PCI.
  • To assess the role of SYNTAX scores in predicting adverse events.

Main Methods:

  • Sixty patients undergoing LMCA PCI were analyzed.
  • Baseline clinical data, SYNTAX score (SS), SS II, and residual SS (rSS) were recorded.
  • Primary endpoints included all-cause death, myocardial infarction (MI), and stroke.

Main Results:

  • A composite endpoint occurred in 26.7% of patients over a median follow-up of 25 months.
  • Higher initial SS, SS II, and rSS were associated with composite endpoints.
  • Creatinine, non-postdilatation, and rSS were independent predictors of adverse outcomes.

Conclusions:

  • CAD severity, assessed by initial and residual SYNTAX scores, is a significant prognostic factor after unprotected LMCA PCI.
  • Increased rSS independently predicts major adverse cardiac and cerebrovascular events and mortality.
  • These findings aid in risk stratification and treatment decisions for LMCA disease.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
128
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
167
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
95
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
196
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
97
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
674